German High Tech News Today

Alentis Therapeutics: Alentis Founder Receives Prestigious French Academy of Science Award Alentis Therapeutics, the Swiss biotech developing breakthrough treatments for fibrotic diseases, announced today that Prof. Thomas Baumert, its founder and world-leading authority in the field, has been awarded the Mémain-Pelletier, French Academy of Science award for his ground-breaking research into understanding the pathogenesis of liver cancer. This press release features multimedia. View the full r...

Alentis Therapeutics, the Swiss biotech developing breakthrough treatments for fibrotic diseases, announced today that Prof. Thomas Baumert, its founder and world-leading authority in the field, has been awarded the Mémain-Pelletier, French Academy of Science award for his ground-breaking research into understanding the pathogenesis of liver cancer. Professor Thomas Baumert, founder of Alentis Therapeutics. Copyright Alentis Therapeutics Said Prof. Thomas Baumert: “It’s a great honor and a...